Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Valneva Se ADR
(NQ:
VALN
)
7.320
-0.020 (-0.27%)
Streaming Delayed Price
Updated: 3:54 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
6,857
Open
7.400
Bid (Size)
7.230 (1)
Ask (Size)
7.360 (1)
Prev. Close
7.340
Today's Range
7.240 - 7.400
52wk Range
6.390 - 14.49
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Why Nikola Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
August 19, 2024
Via
Benzinga
ZIM Integrated Shipping Services Posts Upbeat Earnings, Joins fuboTV, Foghorn Therapeutics And Other Big Stocks Moving Higher On Monday
August 19, 2024
Via
Benzinga
Performance
YTD
-28.51%
-28.51%
1 Month
+3.54%
+3.54%
3 Month
-19.38%
-19.38%
6 Month
+7.65%
+7.65%
1 Year
-47.30%
-47.30%
More News
Read More
Analyst Scoreboard: 8 Ratings For Valneva
August 14, 2024
Via
Benzinga
What Analysts Are Saying About Valneva Stock
July 22, 2024
Via
Benzinga
The Analyst Landscape: 6 Takes On Valneva
June 24, 2024
Via
Benzinga
What Analysts Are Saying About Valneva Stock
May 31, 2024
Via
Benzinga
Cracking The Code: Understanding Analyst Reviews For Valneva
May 08, 2024
Via
Benzinga
VALN Stock Earnings: Valneva Misses EPS, Misses Revenue for Q2 2024
August 13, 2024
Via
InvestorPlace
3 Promising Biotech Stocks You Can Pick Up for Less Than $10
July 29, 2024
Via
InvestorPlace
Pfizer/Valneva's Vaccine Study For Tick-Borne Infection Completes Primary Vaccination Series, Plans Approval In 2026
July 18, 2024
Via
Benzinga
Valneva Seeks Expanded Use For Its Chikungunya Vaccine In Adolescents With Encouraging Phase 3 Data
May 13, 2024
Via
Benzinga
VALN Stock Earnings: Valneva Misses EPS, Misses Revenue for Q1 2024
May 13, 2024
Via
InvestorPlace
What Analysts Are Saying About Valneva Stock
March 22, 2024
Via
Benzinga
VALN Stock Earnings: Valneva Misses Revenue for Q4 2023
March 20, 2024
Via
InvestorPlace
Expert Ratings for Valneva
December 04, 2023
Via
Benzinga
Analyst Ratings for Valneva
November 10, 2023
Via
Benzinga
National CineMedia Reports Upbeat Results, Joins Nordstrom, Core & Main And Other Big Stocks Moving Higher On Tuesday
March 19, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Smith & Wesson Brands Reports Upbeat Earnings, Joins America's Car-Mart, HCI Group And Other Big Stocks Moving Higher On Friday
March 08, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Novavax’s dispute resolution and upcoming earnings call
February 23, 2024
Via
MarketBeat
Topics
Earnings
Exposures
COVID-19
Financial
Analyst Ratings for Valneva
September 07, 2023
Via
Benzinga
Chikungunya Vaccine Maker Valneva Secures Non Dilutive Funding To Develop/Expand Its Clinical Pipeline
February 05, 2024
Via
Benzinga
Exposures
Product Safety
McDonald's, Caterpillar And 3 Stocks To Watch Heading Into Monday
February 05, 2024
Via
Benzinga
Valneva Says Single Chikungunya Vaccine Shows Long-Lasting Antibody Response In Younger, Older Adults
December 04, 2023
Via
Benzinga
FDA Approves World's First Mosquito-Borne Chikungunya Vaccine
November 10, 2023
Via
Benzinga
Exposures
Product Safety
Pfizer, Valneva's Tick-Borne Infection Shot: Companies Say 'Positive' Result For Lyme Disease Vaccine Candidate Booster
September 07, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.